Risk Factors for Cardiac Adverse Events in Infants and Children with Complex Heart Disease Scheduled for Bi-ventricular Repair: Prognostic Value of Pre-operative B-Type Natriuretic Peptide and High-Sensitivity Troponin T

被引:10
作者
Mori, Yoshiki [1 ]
Nakashima, Yasumi [1 ]
Kaneko, Sachie [1 ]
Inoue, Nao [1 ]
Murakami, Tomotaka [1 ]
机构
[1] Seirei Hamamatsu Gen Hosp, Div Pediat Cardiol, Hamamatsu, Shizuoka, Japan
关键词
Natriuretic peptides; Troponin; Complex congenital heart disease; Pediatric cardiac surgery; Risk stratification; PEDIATRIC-PATIENTS; PREDICTIVE-VALUE; SURGERY; MORTALITY; STRATIFICATION; BIOMARKERS; FAILURE; ASSOCIATION; ADJUSTMENT; BYPASS;
D O I
10.1007/s00246-020-02437-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Few reports have described the prognostic value of measuring both B-type natriuretic peptides (BNP) and high-sensitivity troponin T (hs-TnT) in pediatric patients with complex congenital heart disease (CHD) undergoing surgery. We assessed demographic, hemodynamic, and laboratory data, including BNP and hs-TnT levels, for the prediction of cardiac adverse events in 85 patients. Cardiac adverse events were defined as death, cardiac arrest, worsening heart failure requiring inotropic agents and/or respiratory support, and unscheduled surgery/intervention either within or after 12 months of surgery. There were 17 cardiac adverse events. Of the demographic variables, low birth weight (< 2500 g: Odds ratio [OR], 5.97; 95% confidential interval [CI] 1.48-24.0;p = 0.001) and Ross/New York Heart Association [NYHA] class (>= 2.0) (OR 12.7; 95% CI 3.08-52.7;p = 0.0004) were strongly association with cardiac adverse events. Among hemodynamic and laboratory variables, preoperative BNP (OR 14.04; 95% CI 2.15-91.7;p = 0.001) and hs-TnT levels (OR 16.66; 95% CI 2.27-122;p = 0.002) were found to be independent risk factors. Receiver operating characteristic analysis determined BNP and hs-TnT levels of 60.9 pg/mL and 0.025 ng/mL, respectively, to be markers of high risk. Kaplan-Meier analysis demonstrated significant differences in the freedom from cardiac adverse events between Group A (BNP or hs-TnT elevated,n = 26) and Group B (both biomarkers elevated,n = 19; log-rank,p < 0.001). In conclusion, low birth weight (< 2500 g) and Ross/NYHA class >= 2.0 are strongly associated with cardiac adverse events. Preoperative BNP and hs-TnT also provide prognostic information in patients with complex CHD scheduled for surgery. Using both markers in combination predicts cardiac adverse events better than using either separately.
引用
收藏
页码:1756 / 1765
页数:10
相关论文
共 45 条
  • [1] Morbidity and mortality after surgery for congenital cardiac disease in the infant born with low weight
    Ades, Anne M.
    Dominguez, Troy E.
    Nicolson, Susan C.
    Gaynor, James W.
    Spray, Thomas L.
    Wernovsky, Gil
    Tabbutt, Sarah
    [J]. CARDIOLOGY IN THE YOUNG, 2010, 20 (01) : 8 - 17
  • [2] Clinical utility of B-type natriuretic peptide (NP) in pediatric cardiac surgery - a systematic review
    Afshani, Nura
    Schuelein, Simone
    Biccard, Bruce M.
    Thomas, Jenny M.
    [J]. PEDIATRIC ANESTHESIA, 2015, 25 (02) : 115 - 126
  • [3] Low-weight infants are at increased mortality risk after palliative or corrective cardiac surgery
    Alsoufi, Bahaaldin
    Manlhiot, Cedric
    Mahle, William T.
    Kogon, Brian
    Border, William L.
    Cuadrado, Angel
    Vincent, Robert
    McCrindle, Brian W.
    Kanter, Kirk
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 148 (06) : 2508 - U1128
  • [4] European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials
    Apple, FS
    Wu, AHB
    Jaffe, AS
    [J]. AMERICAN HEART JOURNAL, 2002, 144 (06) : 981 - 986
  • [5] The number of primary events per variable affects estimation of the subdistribution hazard competing risks model
    Austin, Peter C.
    Allignol, Arthur
    Fine, Jason P.
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2017, 83 : 75 - 84
  • [6] Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease
    Baggen, Vivan J. M.
    van den Bosch, Annemien E.
    Eindhoven, Jannet A.
    Schut, Anne-Rose W.
    Cuypers, Judith A. A. E.
    Witsenburg, Maarten
    de Waart, Monique
    van Schaik, Ron H. N.
    Zijlstra, Felix
    Boersma, Eric
    Roos-Hesselink, Jolien W.
    [J]. CIRCULATION, 2017, 135 (03) : 264 - +
  • [7] n Survival, by Birth Weight and Gestational Age, in Individuals With Congenital Heart Disease: A Population-Based Study
    Best, Kate E.
    Tennant, Peter W. G.
    Rankin, Judith
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (07):
  • [8] Early elevation of cardiac troponin I is predictive of short-term outcome in neonates and infants with coronary anomalies or reduced ventricular mass undergoing cardiac surgery
    Bojan, Mirela
    Peperstraete, Harlinde
    Lilot, Marc
    Vicca, Stephanie
    Pouard, Philippe
    Vouhe, Pascal
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 144 (06) : 1436 - 1444
  • [9] Biomarkers in heart failure
    Braunwald, Eugene
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (20) : 2148 - 2159
  • [10] Troponin T and B-Type Natriuretic Peptide After On-Pump Cardiac Surgery Prognostic Impact on 12-Month Mortality and Major Cardiac Events After Adjustment for Postoperative Complications
    Buse, Giovanna A. L. Lurati
    Bolliger, Daniel
    Seeberger, Esther
    Kasper, Jorge
    Grapow, Martin
    Koller, Michael T.
    Seeberger, Manfred D.
    Filipovic, Miodrag
    [J]. CIRCULATION, 2014, 130 (12) : 948 - +